Savara Inc Operating Lease Liability
Savara Inc (SVRA) had Operating Lease Liability of $1.09 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability $1.09M.
- 2025-12-31: Operating Lease, Liability $85.00K.
- 2024-12-31: Operating Lease, Liability $230.00K.
- 2023-12-31: Operating Lease, Liability $344.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $85.00K 10-K · filed 2026-03-13 |
| 2024-12-31 | $230.00K 10-K · filed 2025-03-27 |
| 2023-12-31 | $344.00K 10-K · filed 2024-03-07 |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-09 |
| 2022-12-31 | $110.00K 10-K · filed 2023-03-30 |
| 2021-12-31 | $231.00K 10-K · filed 2022-03-30 |
| 2020-12-31 | $253.00K 10-K · filed 2021-03-10 |
| 2020-09-30 | $303.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $357.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $503.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $687.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | $872.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.05M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.21M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |